Motiva (ESTA): Utang-utang marang kapitalisasi buku

Tandha merek Establishment Labs Corp (ESTA)

Establishment Labs relies on a team of cutting-edge engineers developing innovative women's health solutions. Revenue growth is driven by the global promotion of the Motiva brand, and the 11.30 metric confirms its current status. This price action chart below demonstrates the company's market trend. The business minimizes risks by utilizing its own assembly plants for implants, limiting external interaction solely to polymer procurement and transport services.

ESTA - Utang-utang marang aset resik Establishment Labs Inc ing rentang 04.07.2022 - 27.10.2026
Produk asli Establishment Labs Corp

Establishment Labs' expansion into the premium implant segment requires an assessment of financial stability by comparing all liabilities against the net asset value. By analyzing the ratio of total debt to balance sheet capital, an investor determines the extent to which business development depends on borrowed funds, where an increasing value indicates heightened financial leverage and a decrease reflects the strengthening of the company's fundamental autonomy.

Pesaing Establishment Labs

BSX: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku edwards.com EW|RMD: Utang-utang marang kapitalisasi buku|PODD - Utang marang nilai buku|Zimmer Biomet - Utang-utang marang kapitalisasi buku|CooperSurgical (COO) - Utang-utang marang aset resik|ALGN (Align Technology, Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku GMED|Rasio utang marang kapitalisasi buku TransMedics Organ Care System (TMDX)|Rasio utang marang kapitalisasi buku Alphatec Holdings (ATEC)|Utang-utang marang kapitalisasi buku AORT|ENOV - Utang-utang marang aset resik|Utang marang nilai buku Integra LifeSciences|BBNX - Rasio utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku IRMD|Embecta Corp (EMBC) - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Tandem Diabetes (TNDM)|Rasio utang marang nilai buku Axogen Surgical (AXGN)|SI-BONE, Inc. (SIBN) - Utang marang nilai buku|Rasio utang marang aset resik OFIX (orthofix.com)|Bioventus - Rasio utang marang kapitalisasi buku|Utang marang nilai buku OrthoPediatrics Corp KIDS|TMCI (Treace Medical) - Utang-utang marang kapitalisasi buku|SRTA - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Carlsmed Inc|rxsight.com (RXST) - Rasio utang marang nilai buku|CLPT: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Stereotaxis Inc|Utang-utang marang kapitalisasi buku STIM (NeuroStar)|Utang marang nilai buku Sight Sciences Inc (SGHT)|Utang-utang marang kapitalisasi buku OBIO (Orchestra BioMed, Inc.)|Anika Therapeutics Inc. - Utang-utang marang kapitalisasi buku|NSPR - Rasio utang marang kapitalisasi buku|Jin Medical International (ZJYL) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku vivani.com VANI|Xtant Medical (XTNT) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku NMTC (NeuroOne Medical Technologies)|Utang-utang marang nilai buku MODD|MYO: Rasio utang marang kapitalisasi buku|Utang marang aset resik Envoy Medical Inc. COCH|Utang marang nilai buku VVOS (Vivos Therapeutics, Inc)|Utang-utang marang kapitalisasi buku enVVeno Corp NVNO|Utang-utang marang kapitalisasi buku SINT (SINTX Technologies)|TNON: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Lifeward (LFWD)|AMIX (Autonomix Medical) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku IVF|Utang marang nilai buku Bone Biologics Inc|Axonics, Inc. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku BIOL (biolase.com)|DYNT - Rasio utang marang kapitalisasi buku|FNA - Rasio utang marang nilai buku|Utang marang nilai buku INVO Bio INVO